| Hazard Information | Back Directory | [Uses]
Odesivimab is a human monoclonal antibody, targeting Ebola virus glycoprotein with a KD value of 7.74 nM for recombinant histidine-tagged Makona strain Ebola virus glycoprotein ectodomain protein. Odesivimab can be used in research of Ebola virus infection[1]. | [in vivo]
Odesivimab with Atoltivimab and Maftivimab (REGN-3471; 50 mg/kg) has protective effect in the rhesus macaque model of Ebola virus infection[1]. | [References]
[1] Markham A. REGN-EB3: First Approval. Drugs. 2021 Jan;81(1):175-178. DOI:10.1007/s40265-020-01452-3 |
|
| Company Name: |
Biolab Reagents
|
| Tel: |
18108604356 18108604356 |
| Website: |
www.biolabreagent.com/ |
| Company Name: |
Cell Sciences
|
| Tel: |
9785721070 |
| Website: |
www.cellsciences.com |
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|